Skip to main content

Month: June 2024

Surge Copper Announces $1.6M FT Offering To Accelerate Exploration at Berg Project

Vancouver, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) announces a non-brokered private placement of up to 6,666,667 charity flow-through common shares (the “CFT Shares”) at a price of $0.245 per CFT Share for gross proceeds of up to $1.6 million (the “Offering”). Leif Nilsson, Chief Executive Officer, commented: “We are very grateful for the strong support from new and existing investors. Having recently closed a $5 million hard-dollar funding package to advance the Berg Project toward PFS, we have decided to take advantage of the prevailing tax regime to further strengthen our treasury position with this critical minerals flow-through Offering. This will allow Surge to more aggressively test its highest priority exploration targets,...

Continue reading

Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will participate in a fireside chat during the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 11:20 AM ET in Miami, Florida. A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website. About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of...

Continue reading

Abacus Acquires 100% of the Willow Porphyry Copper Property

VANCOUVER, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or “The Company”) (TSXV:AME) is pleased to announce that it has signed an Agreement with Almadex Minerals Ltd. and its wholly-owned Nevada subsidiary Almadex America Inc. (“Almadex”), to acquire a 100% ownership interest in the Willow porphyry copper property located in Yerington, Nevada, (“Willow Property”) and data associated with the Willow Property (the “Willow Data”). Under the terms of the Agreement, which is subject to TSX Venture Exchange (“TSX-V”) approval, Abacus will issue common shares of Abacus (“Shares”) to Almadex, as to:7,500,000 shares in the capital of the Company (“Shares”) (the “Initial Shares”) on closing of the transaction, expected to be on or about June 30, 2024 (the “Closing Date”); and, on...

Continue reading

ABM Reports Second Quarter Fiscal 2024 Results and Raises Outlook for Fiscal Year 2024 Adjusted EPS

Revenue up 2% to $2.0 billion, all organic growth Net income of $43.8 million and GAAP EPS of $0.69, declines of 16% and 12%, respectively Adjusted EBITDA of $125.3 million, down 9% Adjusted EPS of $0.87, down 3% Operating cash flow of $117.0 million and free cash flow of $101.4 million, both up significantly Raises outlook for fiscal year 2024 adjusted EPS to $3.40 to $3.50, up from $3.30 to $3.45 (1)NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the second quarter of fiscal 2024. “We are pleased with our second quarter results, which were driven by our team’s outstanding execution and highlighted by strong cash flow, as well as mid-single digit organic revenue growth in our Aviation, Technical Solutions, Manufacturing & Distribution...

Continue reading

Hooker Furnishings Reports First Quarter Operating Results and Cost Reduction Plan

MARTINSVILLE, Va., June 06, 2024 (GLOBE NEWSWIRE) — Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (the “Company” or “HFC”), a global leader in the design, production, and marketing of home furnishings for 100 years, today reported its fiscal 2025 first quarter operating results for the period beginning January 29 and ending April 28, 2024. Fiscal 2025 first quarter overview and expected cost reductions:Consolidated net sales for the quarter were $93.6 million, a decrease of $28.2 million, or 23.2%, compared to the prior year’s first quarter. All three reporting segments experienced sales decreases driven mostly by continuing weak demand for home furnishings which is adversely affecting much of the industry. Additionally, about 25% of the quarterly decrease is due to absence of sales from divisions exited in the prior year...

Continue reading

Jiayin Group Inc. Reports First Quarter 2024 Unaudited Financial Results

— First Quarter Total Loan Facilitation Volume Grew 13.6% to RMB22.5 billion —— First Quarter Net Revenue Grew 31.5% to RMB1,475.3 million — SHANGHAI, June 06, 2024 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Operational and Financial Highlights:Loan facilitation volume1 was RMB22.5 billion (US$3.1 billion), representing an increase of 13.6% from the same period of 2023. Average borrowing amount per borrowing was RMB10,570 (US$1,464), representing an increase of 6.6% from the same period of 2023. Repeat borrowing rate2 was 73.0%, compared with 67.8% in the same period of 2023. Net revenue was RMB1,475.3 million (US$204.3...

Continue reading

Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL

Company announcement – No. 29 / 2024 Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL Copenhagen, Denmark, June 6, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) today announced that an embargoed abstract of positive results from Boehringer Ingelheim’s Phase 2 trial of survodutide (BI 456906) in metabolic dysfunction-associated steatohepatitis (MASH) due to be presented at the European Association of the Study of Liver Congress (EASL) 2024 on June 7 was unintentionally and temporarily made available through the congress website. Today’s company announcement follows topline data announced earlier this year (Company announcement 8/2024) that the double-blind, placebo-controlled Phase 2 trial investigating three doses of survodutide at 2.4 mg, 4.8 mg, and...

Continue reading

Parsons Receives Sustainability Award from Yukon Government

Company Recognized For Sustainable Practices at Faro Mine CHANTILLY, Va., June 06, 2024 (GLOBE NEWSWIRE) — Parsons announced today that the company had received the Yukon Regional Business Sustainability Award for its Faro Mine Remediation project in Yukon, Canada. This inaugural award celebrates Yukon businesses dedicated to building a greener economy by integrating sustainable practices into business models, while prioritizing First Nations reconciliation and collaboration. The Environmental Careers Organization (ECO) of Canada delivered this groundbreaking recognition in partnership with the Yukon Government’s Department of Economic Development. Parsons received the award at this year’s ECO Impact Awards Ceremony recognizing the efforts of Yukon businesses that champion sustainability. One critical objective on the project has...

Continue reading

Nevada Copper Provides Update on Financing Efforts and Liquidity

YERINGTON, Nev., June 06, 2024 (GLOBE NEWSWIRE) — Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) provides an update to its previously disclosed financing efforts. As discussed in recent press releases and securities filings, the Company continues to require further funding to maintain operations and complete the commissioning and ramp-up of its Pumpkin Hollow underground mine located in Yerington, Nevada. The Company has engaged in discussions with its key stakeholders and other parties to obtain funding and/or enter into a change of control transaction. However, at this time the Company has neither a binding offer for a transaction of this kind nor any offer of adequate and sufficient ordinary course funding to continue operations. Pala Investments Limited (“Pala”) and other existing stakeholders...

Continue reading

NIO Inc. Reports Unaudited First Quarter 2024 Financial Results

SHANGHAI, June 06, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced its unaudited financial results for the first quarter ended March 31, 2024. Operating Highlights for the First Quarter of 2024Vehicle deliveries were 30,053 in the first quarter of 2024, consisting of 17,809 premium smart electric SUVs and 12,244 premium smart electric sedans, representing a decrease of 3.2% from the first quarter of 2023, and a decrease of 39.9% from the fourth quarter of 2023.Key Operating Results      2024 Q1 2023 Q4 2023 Q3 2023 Q2Deliveries 30,053 50,045 55,432 23,520           2023 Q1 2022 Q4 2022 Q3 2022 Q2Deliveries 31,041 40,052 31,607 25,059Financial Highlights for the First...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.